Teladoc Health Statistics
Total Valuation
Teladoc Health has a market cap or net worth of $1.98 billion. The enterprise value is $2.33 billion.
Important Dates
The next confirmed earnings date is Wednesday, February 26, 2025, after market close.
| Earnings Date | Feb 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Teladoc Health has 172.17 million shares outstanding. The number of shares has increased by 3.23% in one year.
| Current Share Class | 172.17M |
| Shares Outstanding | 172.17M |
| Shares Change (YoY) | +3.23% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 0.93% |
| Owned by Institutions (%) | 68.59% |
| Float | 158.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.75 |
| Forward PS | 0.76 |
| PB Ratio | 1.31 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.97 |
| P/OCF Ratio | 5.87 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 35.15, with an EV/FCF ratio of 7.01.
| EV / Earnings | n/a |
| EV / Sales | 0.90 |
| EV / EBITDA | 35.15 |
| EV / EBIT | n/a |
| EV / FCF | 7.01 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 1.05.
| Current Ratio | 1.73 |
| Quick Ratio | 1.58 |
| Debt / Equity | 1.05 |
| Debt / EBITDA | 20.05 |
| Debt / FCF | 4.79 |
| Interest Coverage | -8.74 |
Financial Efficiency
Return on equity (ROE) is -51.65% and return on invested capital (ROIC) is -3.52%.
| Return on Equity (ROE) | -51.65% |
| Return on Assets (ROA) | -3.13% |
| Return on Invested Capital (ROIC) | -3.52% |
| Return on Capital Employed (ROCE) | -7.57% |
| Revenue Per Employee | $462,430 |
| Profits Per Employee | -$175,308 |
| Employee Count | 5,600 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 20.73 |
Taxes
In the past 12 months, Teladoc Health has paid $10.87 million in taxes.
| Income Tax | 10.87M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.83% in the last 52 weeks. The beta is 1.05, so Teladoc Health's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -43.83% |
| 50-Day Moving Average | 10.56 |
| 200-Day Moving Average | 9.72 |
| Relative Strength Index (RSI) | 48.93 |
| Average Volume (20 Days) | 10,516,371 |
Short Selling Information
The latest short interest is 22.93 million, so 13.32% of the outstanding shares have been sold short.
| Short Interest | 22.93M |
| Short Previous Month | 23.53M |
| Short % of Shares Out | 13.32% |
| Short % of Float | 14.50% |
| Short Ratio (days to cover) | 5.71 |
Income Statement
In the last 12 months, Teladoc Health had revenue of $2.59 billion and -$981.73 million in losses. Loss per share was -$5.81.
| Revenue | 2.59B |
| Gross Profit | 1.83B |
| Operating Income | -196.55M |
| Pretax Income | -997.92M |
| Net Income | -981.73M |
| EBITDA | 66.19M |
| EBIT | -196.55M |
| Loss Per Share | -$5.81 |
Full Income StatementBalance Sheet
The company has $1.24 billion in cash and $1.59 billion in debt, giving a net cash position of -$345.01 million or -$2.00 per share.
| Cash & Cash Equivalents | 1.24B |
| Total Debt | 1.59B |
| Net Cash | -345.01M |
| Net Cash Per Share | -$2.00 |
| Equity (Book Value) | 1.51B |
| Book Value Per Share | 8.77 |
| Working Capital | 677.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $337.86 million and capital expenditures -$6.06 million, giving a free cash flow of $331.80 million.
| Operating Cash Flow | 337.86M |
| Capital Expenditures | -6.06M |
| Free Cash Flow | 331.80M |
| FCF Per Share | $1.93 |
Full Cash Flow StatementMargins
Gross margin is 70.82%, with operating and profit margins of -7.59% and -37.91%.
| Gross Margin | 70.82% |
| Operating Margin | -7.59% |
| Pretax Margin | -37.49% |
| Profit Margin | -37.91% |
| EBITDA Margin | 2.56% |
| EBIT Margin | -7.59% |
| FCF Margin | 12.81% |
Dividends & Yields
Teladoc Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.23% |
| Shareholder Yield | -3.23% |
| Earnings Yield | -49.54% |
| FCF Yield | 16.74% |
Dividend DetailsAnalyst Forecast
The average price target for Teladoc Health is $12.18, which is 5.82% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.18 |
| Price Target Difference | 5.82% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 1.91% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Teladoc Health has an Altman Z-Score of -4.93 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.93 |
| Piotroski F-Score | 5 |